Back
82
Day Range
$47.60
$49.98
52-Week Range
$36.22
$104.32
Volume
4,698,160
50D / 200D Avg
$57.60
/
$69.23
Prev Close
$46.96
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -34.8 | 0.4 |
| P/B | 17.4 | 2.9 |
| ROE % | -89.5 | 3.7 |
| Net Margin % | -19.3 | 3.8 |
| Rev Growth 5Y % | 49.0 | 10.0 |
| D/E | 1.7 | 0.2 |
Key Takeaways
Revenue grew 49.03% annually over 5 years — strong growth
Negative free cash flow of -239.14M
PEG of 0.61 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 34.38%
Capital efficient — spends only 1.66% of revenue on capex
Growth
Revenue Growth (5Y)
49.03%
Revenue (1Y)83.41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-89.48%
ROIC-13.69%
Net Margin-19.27%
Op. Margin-18.76%
Safety
Debt / Equity
1.66
Current Ratio3.13
Interest Coverage-3.40
Valuation
P/E Ratio
-34.84
P/B Ratio17.38
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 83.41% | Revenue Growth (3Y) | 54.64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 49.03% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.27B | Net Income (TTM) | -245.03M |
| ROE | -89.48% | ROA | -10.77% |
| Gross Margin | 69.64% | Operating Margin | -18.76% |
| Net Margin | -19.27% | Free Cash Flow (TTM) | -239.14M |
| ROIC | -13.69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.66 | Current Ratio | 3.13 |
| Interest Coverage | -3.40 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -34.84 | P/B Ratio | 17.38 |
| P/S Ratio | 6.71 | PEG Ratio | 0.61 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 8.54B | Enterprise Value | 8.75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.27B | 693.40M | 531.82M | 320.67M | 257.85M |
| Net Income | -245.03M | -705.81M | -214.12M | -289.81M | -259.19M |
| EPS (Diluted) | -1.41 | -4.60 | -1.73 | -1.97 | -1.75 |
| Gross Profit | 885.69M | 381.11M | 286.18M | 130.19M | 83.64M |
| Operating Income | -238.64M | -691.08M | -196.08M | -265.44M | -243.71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.27B | 926.12M | 564.05M | 631.36M | 531.35M |
| Total Liabilities | 1.78B | 869.78M | 1.95B | 1.76B | 1.34B |
| Shareholders' Equity | 491.33M | 56.34M | -1.38B | -1.13B | -807.49M |
| Total Debt | 815.71M | 468.09M | 488.14M | 433.03M | 238.95M |
| Cash & Equivalents | 604.79M | 340.95M | 165.77M | 302.94M | 277.69M |
| Current Assets | 1.17B | 667.60M | 350.33M | 438.63M | 403.99M |
| Current Liabilities | 372.39M | 291.07M | 232.63M | 174.24M | 114.81M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#3 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026